$GYHT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.

Page:   1 2 3 4 5 ... 15 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 06 2021GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.005,2300128,983123.8 K to 129 K (+4.23 %)
May 06 2021GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGrantA0.005,2300213,983208.8 K to 214 K (+2.51 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Henderson Jeffrey WilliamDirectorGrantA0.005,230052,83947.6 K to 52.8 K (+10.99 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.005,230026,23221 K to 26.2 K (+24.90 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.005,230032,01326.8 K to 32 K (+19.53 %)
May 06 2021GYHTHALOZYME THERAPEUT ...BIZZARI JEAN-PIERREDirectorGrantA0.005,230087,54482.3 K to 87.5 K (+6.35 %)
May 03 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM11.2911,311127,7010
May 03 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM11.2911,311127,701134,111122.8 K to 134.1 K (+9.21 %)
Apr 14 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS45.005,000225,000179,833184.8 K to 179.8 K (-2.71 %)
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM14.6650,000733,000500,000
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS42.5550,0002,127,250537,160587.2 K to 537.2 K (-8.52 %)
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM14.6650,000733,000587,160537.2 K to 587.2 K (+9.31 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM11.2928,689323,89911,311
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS42.7918,994812,829122,800141.8 K to 122.8 K (-13.40 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS42.119,695408,208141,794151.5 K to 141.8 K (-6.40 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM11.2928,689323,899151,489122.8 K to 151.5 K (+23.36 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseM0.0010,196030,600
Apr 01 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Payment of ExerciseF42.434,059172,22314,01818.1 K to 14 K (-22.45 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...BuyM0.0010,196018,0777.9 K to 18.1 K (+129.37 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS46.0850023,042184,833185.3 K to 184.8 K (-0.27 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS45.264,500203,675185,333189.8 K to 185.3 K (-2.37 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS46.266,530302,061122,800129.3 K to 122.8 K (-5.05 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS45.5611,794537,303129,330141.1 K to 129.3 K (-8.36 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM14.6650,000733,000550,000
Mar 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS46.4833,8901,575,112537,160571.1 K to 537.2 K (-5.93 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS45.5816,110734,342571,050587.2 K to 571.1 K (-2.74 %)
Mar 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM14.6650,000733,000587,160537.2 K to 587.2 K (+9.31 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,80300
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF48.694,364212,483141,124145.5 K to 141.1 K (-3.00 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,8030145,488136.7 K to 145.5 K (+6.44 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,35400
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF48.6919,511949,991537,160556.7 K to 537.2 K (-3.50 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540556,671517.3 K to 556.7 K (+7.61 %)
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0013,544013,544
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA49.8423,3111,161,82023,311
Feb 17 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0014,898014,898
Feb 17 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA49.8425,6421,277,99725,642
Feb 17 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.0052,368052,368
Feb 17 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA49.8490,1344,492,27990,134
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,729028,729
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF49.8414,243709,871517,317531.6 K to 517.3 K (-2.68 %)
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7290531,560502.8 K to 531.6 K (+5.71 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,12908,258
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,257018,769
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF49.842,047102,02216,57818.6 K to 16.6 K (-10.99 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,129018,62514.5 K to 18.6 K (+28.48 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF50.603,203162,07214,49617.7 K to 14.5 K (-18.10 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,257017,69911.4 K to 17.7 K (+54.68 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.007,883015,766
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,134024,399
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF49.842,725135,814133,186135.9 K to 133.2 K (-2.00 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.007,8830135,911128 K to 135.9 K (+6.16 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF50.602,906147,044128,028130.9 K to 128 K (-2.22 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,1340130,934122.8 K to 130.9 K (+6.62 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0032,795065,589
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0031,282093,844
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF49.8416,259810,349502,831519.1 K to 502.8 K (-3.13 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0032,7950519,090486.3 K to 519.1 K (+6.74 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF50.6015,509784,755486,295501.8 K to 486.3 K (-3.09 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0031,2820501,804470.5 K to 501.8 K (+6.65 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS48.6924611,977189,833190.1 K to 189.8 K (-0.13 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS48.094,754228,617190,079194.8 K to 190.1 K (-2.44 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM14.6650,000733,000600,000
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS48.515,437263,736470,522476 K to 470.5 K (-1.14 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS47.7644,5632,128,182475,959520.5 K to 476 K (-8.56 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM14.6650,000733,000520,522470.5 K to 520.5 K (+10.63 %)
Jan 04 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS43.3829012,581194,833195.1 K to 194.8 K (-0.15 %)
Jan 04 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS42.884,710201,974195,123199.8 K to 195.1 K (-2.36 %)
Dec 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS43.2560025,951122,800123.4 K to 122.8 K (-0.49 %)
Dec 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS42.5411,400484,967123,400134.8 K to 123.4 K (-8.46 %)
Nov 30 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOGiftG0.0010,0000470,522480.5 K to 470.5 K (-2.08 %)
Nov 27 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS41.2510,000412,500266,711276.7 K to 266.7 K (-3.61 %)
Nov 27 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS41.509,671401,350276,711286.4 K to 276.7 K (-3.38 %)
Nov 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS39.047,889307,955134,800142.7 K to 134.8 K (-5.53 %)
Nov 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS38.244,111157,221142,689146.8 K to 142.7 K (-2.80 %)
Oct 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS30.4312,000365,148146,800158.8 K to 146.8 K (-7.56 %)
Oct 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS30.4312,000365,148146,800158.8 K to 146.8 K (-7.56 %)
Sep 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS26.9112,000322,884158,800170.8 K to 158.8 K (-7.03 %)
Sep 14 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGiftG0.008,0000208,753216.8 K to 208.8 K (-3.69 %)
Sep 14 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorSellS27.0632,000865,792216,753248.8 K to 216.8 K (-12.86 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,884013,766
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF27.702,38065,92611,44213.8 K to 11.4 K (-17.22 %)
Sep 04 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,884013,8226.9 K to 13.8 K (+99.22 %)
Aug 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS28.3012,000339,564170,800182.8 K to 170.8 K (-6.56 %)
Aug 13 2020GYHTHALOZYME THERAPEUT ...Daly James MDirectorSellS29.1234,337999,89331,36565.7 K to 31.4 K (-52.26 %)
Jul 20 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS29.0112,000348,072182,800194.8 K to 182.8 K (-6.16 %)
May 22 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM7.1418,613132,8970
May 22 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM7.1418,613132,897194,800176.2 K to 194.8 K (+10.56 %)
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM7.1421,387152,70318,613
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS23.8021,387509,075176,187197.6 K to 176.2 K (-10.82 %)
May 21 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM7.1421,387152,703197,574176.2 K to 197.6 K (+12.14 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.008,8290123,753114.9 K to 123.8 K (+7.68 %)
May 01 2020GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGrantA0.008,8290248,753239.9 K to 248.8 K (+3.68 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorGrantA0.008,8290286,382277.6 K to 286.4 K (+3.18 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Henderson Jeffrey WilliamDirectorGrantA0.008,829072,10763.3 K to 72.1 K (+13.95 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.008,829065,70256.9 K to 65.7 K (+15.52 %)
May 01 2020GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.008,829026,78318 K to 26.8 K (+49.18 %)
May 01 2020GYHTHALOZYME THERAPEUT ...BIZZARI JEAN-PIERREDirectorGrantA0.008,829082,31473.5 K to 82.3 K (+12.01 %)
Apr 03 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0040,796040,796
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.2417,543249,781277,553260 K to 277.6 K (+6.75 %)
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.2517,543249,982260,010242.5 K to 260 K (+7.24 %)
Mar 19 2020GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorBuyP14.1917,543248,933242,467224.9 K to 242.5 K (+7.80 %)
Mar 04 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0048,662048,662
Mar 04 2020GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA20.55104,9692,157,113104,969
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,80308,803
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF21.833,04466,451176,187179.2 K to 176.2 K (-1.70 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,8030179,231170.4 K to 179.2 K (+5.17 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392011,392
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF21.834,50898,410116,167120.7 K to 116.2 K (-3.74 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,3920120,675109.3 K to 120.7 K (+10.42 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,354039,354
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF21.8319,511425,925490,522510 K to 490.5 K (-3.83 %)
Feb 24 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540510,033470.7 K to 510 K (+8.36 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.005,772011,542
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF21.101,99542,095170,428172.4 K to 170.4 K (-1.16 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.005,7720172,423166.7 K to 172.4 K (+3.46 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,730057,458
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF21.1014,244300,548470,679484.9 K to 470.7 K (-2.94 %)
Feb 18 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7300484,923456.2 K to 484.9 K (+6.30 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,130012,387
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF20.001,68133,6206,9388.6 K to 6.9 K (-19.50 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,13008,6194.5 K to 8.6 K (+92.00 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.007,883023,649
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF20.002,72554,500166,651169.4 K to 166.7 K (-1.61 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.007,8830169,376161.5 K to 169.4 K (+4.88 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,26200
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF20.003,89477,880104,174108.1 K to 104.2 K (-3.60 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,2620108,06896.8 K to 108.1 K (+11.63 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0032,795098,384
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF20.0016,259325,180456,193472.5 K to 456.2 K (-3.44 %)
Feb 13 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0032,7950472,452439.7 K to 472.5 K (+7.46 %)
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0025,026025,026
Feb 12 2020GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA19.9853,2111,063,15653,211
Feb 12 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseA0.0032,533032,533
Feb 12 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseA19.9869,1741,382,09769,174
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0032,533032,533
Feb 12 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA19.9869,1741,382,09769,174
Feb 12 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.00125,1260125,126
Feb 12 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA19.98266,0515,315,699266,051
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.0011,55900
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF19.214,28982,392161,493165.8 K to 161.5 K (-2.59 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.0011,5590165,782154.2 K to 165.8 K (+7.49 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0055,48700
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2119,910382,471439,657459.6 K to 439.7 K (-4.33 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0055,4870459,567404.1 K to 459.6 K (+13.73 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.0011,55900
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF19.214,28982,392161,493165.8 K to 161.5 K (-2.59 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.0011,5590165,782154.2 K to 165.8 K (+7.49 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0055,48700
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2119,910382,471439,657459.6 K to 439.7 K (-4.33 %)

Page:   1 2 3 4 5 ... 15 next >